NEW YORK, Oct. 7, 2014 /PRNewswire/ -- Levi & Korsinsky
is investigating the Board of Directors of Durata Therapeutics Inc.
("Durata" or "the Company") (NASDAQ: DRTX) for possible breaches of
fiduciary duty and other violations of state law in connection with
the sale of the Company to Actavis (NYSE: ACT).
Click here to learn more about the investigation:
http://zlk.9nl.com/durata-therapeutics-drtx.
Under the terms of the transaction, Durata shareholders will
receive $23.00 in cash for each share
of Durata stock they own, as well as contingent value rights
entitling the holder to receive additional cash payments of up to
$5.00 per share upon certain achieved
milestones. The investigation concerns whether the Board of Durata
breached their fiduciary duties to stockholders by failing to
adequately shop the Company before agreeing to enter into this
transaction, and whether Actavis is underpaying for Durata
shares.
If you own Durata common stock and wish to obtain additional
information, please contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/durata-therapeutics-drtx.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
SOURCE Levi & Korsinsky, LLP